ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1100

Identification of Rapid Decline of Kidney Function in Older Adults with Different Types of Aging

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Wang, Mengjing, Nephrology, Huashan Hospital, Fudan University, Shanghai, China
  • Chen, Jing, Nephrology, Huashan Hospital, Fudan University, Shanghai, China
Background

This study aims to assess the role of glomerular filtration rate (GFR) combined with urine albumin-creatinine ratio (ACR) in predicting rapid kidney function decline (>30% decline in GFR within 2 years) across older adults with three types of aging (healthy aging, aging with comorbidities, aging with nephropathy).

Methods

Categorical analyses were conducted using data from the Rugao Longevity and Aging Study (RLAS) cohort in China (470 older adults with healthy aging and 505 with comorbidities) and healthcare data from Huashan Hospital of Fudan University (315 older adults with nephropathy) between 2011 and 2022. Corrected (age) absolute risk probabilities (aAR) were calculated for different GFR and ACR intervals, stratified by aging category. Finally, the importance of different categories of GFR and ACR in different aging populations for determining rapid decline in kidney function was identified based on random forest (RF) models.

Results

Compared to the healthy group, the risk of rapid decline of kidney function was generally higher in the comorbidity group and highest in the nephropathy group across all GFR combined with ACR categories. The risk thresholds varied among the three populations: for the healthy group, ACR >30 mg/g combined with GFR <75 ml/min/1.73 m2 (moderate risk); for the comorbidity group, ACR >30 mg/g (moderate risk), particularly with GFR <60 ml/min/1.73 m2 (high risk); and for the nephropathy group, at all stages (moderate risk), particularly ACR >30 mg/g combined with GFR <75 ml/min/1.73 m2(high risk). Besides, GFR is of the most importance in distinguishing rapid decline in kidney function, but the discrimination of GFR decreases with the occurrence of comorbidities and kidney diseases, while the discrimination of ACR increases in this two populations.

Conclusion

The thresholds for GFR and ACR to predict rapid decline in kidney function in the elderly population need to be established according to different types of aging.

Funding

  • Government Support – Non-U.S.